During the past decade, Klinikum Kempten - Oberallgaeu conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Kempten - Oberallgaeu" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials, followed by "German CLL Study Group" with 2 trials sponsored, "Heidelberg University" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "AGO Research GmbH" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Kempten - Oberallgaeu" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Kempten - Oberallgaeu" are "Leukemia" (3 trials), "Lymphoma" (3 trials), "Breast Cancer" (2 trials), "Chronic Lymphocytic Leukemia" (2 trials) and "Chronic Myeloid Leukemia" (2 trials). Many other conditions were trialed in "Klinikum Kempten - Oberallgaeu" in a lesser frequency.

Most popular intervention types in "Klinikum Kempten - Oberallgaeu" are "Drug" (18 trials), "Biological" (7 trials), "Other" (5 trials), "Radiation" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "doxorubicin hydrochloride" (3 trials), "prednisone" (3 trials), "radiation therapy" (3 trials) and "rituximab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Kempten - Oberallgaeu" are 18 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Kempten - Oberallgaeu". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Klinikum Kempten - Oberallgaeu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Kempten - Oberallgaeu, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".